M

MPLT

MPLT

UnknownUnknown

Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.

Insider Sentiment
Based on recent trading activity
0%Bearish
Buy/Sell Ratio0% buys
BearishBullish
MPLT Live QuoteReal-time
$6.42
$1.74(-21.32%)1M
Day Range$6.38 – $6.82
Open$6.63
Previous Close$6.65
Volume416.1K
Key Financials & Valuation
Fundamental balance sheet & market metrics
HEALTHCARE
Market Cap$369.58M
P/E Ratio (TTM)24.5
Forward P/ENaN
EPS (TTM)$-6.07
Price to Book0.8
Dividend Yield0.65%
Beta (Volatility)1.18
IndustryBIOTECHNOLOGY
52-Week RangeCurrent: $6.42 (1%)
Low: $6.06High: $40.43
Wall Street Consensus
Sell
Analyst Rating
2.2/ 5.0
Target Price
$26.15-82.6% upside

Insider Buys

0

$0

Insider Sales

6

$1.06M

Total Volume

$1.06M

23 transactions

Net Activity

$1.06M

Net selling

Proprietary Ratings
Calculated from Form 4 transactions
25CONFIDENCE

Sentiment Rating

Moderate Distribution

CEO Conviction Index

Liquidating / Profit Taking

Key Drivers

  • •Heavy distribution: sales represent 100% of total transaction value.
  • •CEO selling activity detected. Often driven by option expiration or diversification plans.
Score Methodology

The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:

  • +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
  • +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
  • +15CEO Buying: CEO committing own capital shows high conviction.
  • +10CFO Buying: CFO purchasing shares shows financial alignment.
Top Insiders
Most active traders
M
1

Multiple Insiders

S - Sale Insiders

0 buys17 sells

$3515.02B total

K
2

Kroeger Christopher A.

CEO

0 buys1 sells

$595K total

F
3

Foff Erin Pennock

Chief Medical Officer

0 buys1 sells

$124K total

K
4

Kreitzer Anatol

Chief Discovery Officer

0 buys1 sells

$96K total

L
5

Lillie James Woodruff

Chief Scientific Officer

0 buys1 sells

$93K total

Trading History
MPLT insider transactions from SEC Form 4 filings
DateInsiderTypeSharesPriceValueFiling

Oct 15, 2026

1 months ago

Kreitzer Anatol

Chief Discovery Officer

C-Level
Sell12.2K$7.84$96K

Oct 15, 2026

1 months ago

Kroeger Christopher A.

CEO

CEO
Sell73.7K$8.08$595K

Oct 15, 2026

1 months ago

Foff Erin Pennock

Chief Medical Officer

C-Level
Sell15.4K$8.08$124K

Oct 15, 2026

1 months ago

Hanson Kristopher

GC

General Counsel
Sell9.0K$8.08$73K

Oct 15, 2026

1 months ago

Lillie James Woodruff

Chief Scientific Officer

C-Level
Sell11.5K$8.08$93K

Oct 15, 2026

1 months ago

Gillis Jonathan

CAO, Interim CFO

CFO
Sell10.2K$8.08$82K

Sep 16, 2026

2 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell137.0K$-16509.00$0

Aug 3, 2026

3 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell202.4K$-22082.00$0

Jul 28, 2026

3 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell23.5K$15620.00$366.82M

Jul 15, 2026

4 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell144.2K$-36979.00$0

May 18, 2026

6 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell1.39M$-118235.00$0

May 7, 2026

6 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell1.61M$-68491.00$0

May 11, 2026

6 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell162.3K$-13917.00$0

May 4, 2026

6 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell356.3K$-36371.00$0

Apr 27, 2026

6 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell181.2K$-69835.00$0

Apr 15, 2026

7 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell256.6K$-3316.00$0

Feb 20, 2026

9 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell356.7K$-14195.00$0

Feb 18, 2026

9 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell25.0K$25000.00$625.00M

Feb 13, 2026

9 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell370.9K$-12116.00$0

Feb 10, 2026

9 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell63.6K$14124.00$898.98M

Feb 2, 2026

9 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell389.9K$-7040.00$0

Jan 28, 2026

9 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell396.9K$-34398.00$0

Oct 28, 2025

12 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell3.69M$952941.00$3513.13B
Sector & Industry Benchmarks
Unknown Comparison Overview
Industry Buy Conviction6%
MPLT Buy Conviction0%
Industry Rank#0 of 570
Volume Contribution0.0%
Total Industry Activity$16.44B

MPLT has an insider buy conviction of 0%, compared to the Unknown sector buy average of 6%.

Insider Trading Summary & Commentary
Automated executive transaction analysis for MPLT

Over the last 90 days, corporate insiders at MPLT (MPLT) engaged in a total of 23 transactions reported via SEC Form 4 filings. Among these, 0 were open-market purchases and 6 were sales. The total volume of insider trading reached $1.06M.

The net insider activity for MPLT shows a net selling bias of $1.06M. This activity represents a 0% buy ratio, suggesting that insiders are currently bearish on the company's near-term outlook relative to recent history.

The most notable individual transaction was a Sale by Multiple Insiders (P - Purchase Insiders), who traded 3.69M shares valued at $3513.13B on Oct 28, 2025.

Live Market News & Developments
Aggregated real-time headlines for MPLT (MPLT)
6 updates

Is MapLight Therapeutics (MPLT) Fully Valued As Its Shares Hold Near $36.56?

Yahoo Finance116d ago

A $463 million cash position is expected to back MapLight’s planned and ongoing drug trials through 2028.

Stock Titan3d ago

Should I buy MapLight Therapeutics, Inc. (MPLT)

Zacks Investment Research36d ago

MapLight Therapeutics stock tumbles 50% on mixed phase 2 schizophrenia data (MPLT:NASDAQ)

Seeking Alpha115d ago

MPLT - MapLight Therapeutics Inc Stock Price and Quote

Finviz176d ago

Maplight Therapeutics (NASDAQ:MPLT) Stock Rating Reaffirmed as Buy by Canaccord Genuity Group

MarketBeat2d ago

FAQs About MPLT Insider Trading

Answers to common questions regarding corporate filings and executive sentiment for MPLT.

Based on SEC Form 4 disclosures, the Insider Confidence Score for MPLT is currently 25/100, which reflects a moderate distribution bias. This calculation accounts for a total of 0 purchases and 6 sales by company executives over the last 90 days.

The CEO Conviction Index for MPLT is rated as "Liquidating / Profit Taking". Executive buying is typically a strong vote of confidence as C-level leaders have the most intimate knowledge of their firm's prospects. Officer selling, on the other hand, is often routine and does not automatically signal operational weakness.

No. Insider tracking is a highly informative technical signal that indicates executive sentiment, but it should not be the sole basis for a transaction. Investors should combine this filing analysis with company financials, sector trends, and risk management criteria.